Nicholas Souder, MD
Orthopaedic Surgery · Mountain Home, ARNPI 1598910481
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Arthrex at 48.0% of the total. Reporting peaked in 2023 at $1,282 and has fallen 89.5% since, to $135 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in AR, where the typical reported total is $2,620.
Across 31 payments — averaging $71.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Stryker$747
- Rattan And Associates$185
- Zimmer Biomet$125
- Smith+Nephew$63
- AbbVie$27
- plus $11 from 1 others
What the payments were for
- Travel & lodging$1,12450%
- Food & beverage$1,10450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 16 | $1,070 |
| Stryker | 8 | $747 |
| Rattan And Associates | 2 | $185 |
| Zimmer Biomet | 1 | $125 |
| Smith+Nephew | 2 | $63 |
| AbbVie | 1 | $27 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,228 in reported general payments places this provider in the 40th percentile of 168 orthopaedic surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 262 | $4,003 |
| Cefadroxil | 18 | $359 |
| Oxycodone Hcl | 80 | $358 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $346 |
| Meloxicam | 114 | $341 |
| Ondansetron OdtOndansetron | 20 | $222 |
| Etodolac | 11 | $203 |
| Tramadol Hcl | 63 | $196 |
| Gabapentin | 17 | $195 |
| Diclofenac Sodium | 13 | $133 |
| Methylprednisolone | 11 | $94 |
| Dexamethasone | 12 | $79 |
| Ibuprofen | 11 | $43 |
| Tizanidine Hcl | 16 | $37 |
| Amoxicillin | 20 | $22 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mountain Home
- Benjamin StronachLittle Rock$2.5M
- Charles BarnesLittle Rock$2.1M
- Kenneth MartinLittle Rock$322K
- Wesley CoxFayetteville$309K
- William HefleyNorth Little Rock$306K
- David BumpassLittle Rock$175K
- Lawrence O'MalleyLittle Rock$151K
- Jason BrandtJonesboro$104K
- Jason SmithLittle Rock$102K
- Richard McCarthyLittle Rock$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.